Onglyza®, new inhibitor of DPP-4, now available and repaid

被引：0
|
作者：
不详
机构：
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2010年 / 14卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：309 / 309
页数：1
相关论文
共 50 条
  • [1] Use of saxagliptin [Onglyza] is now contraindicated in patients with a history of serious hypersensitivity reaction to any DPP-4 inhibitor,
    Reactions Weekly, 2012, 1396 (1) : 3 - 3
  • [2] Sitagliptin: A DPP-4 Inhibitor
    McDermaid, Karen
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2007, 60 : 21 - 21
  • [3] Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design
    Liang, Gui-Bai
    Qian, Xiaoxia
    Biftu, Tesfaye
    Singh, Suresh
    Gao, Ying-Duo
    Scapin, Giovanna
    Patel, Sangita
    Leiting, Barbara
    Patel, Reshma
    Wuc, Joseph
    Zhang, Xiaoping
    Thornberry, Nancy A.
    Weber, Ann E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (13) : 3706 - 3710
  • [4] Onglyza (R), DPP - 4 inhibitor, anti-diabetic type incretinomimetique
    Buxeraud, Jacques
    ACTUALITES PHARMACEUTIQUES, 2010, 49 (501): : 11 - 12
  • [5] Linagliptin (Tradjenta) - A New DPP-4 Inhibitor for Type 2 Diabetes
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1367): : 49 - 50
  • [6] DPP-4 inhibitor-related pemphigoid
    Reactions Weekly, 2024, 1997 (1) : 3 - 3
  • [7] Saxagliptin: a new DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
    Abd A. Tahrani
    Milan K. Piya
    Anthony H. Barnett
    Advances in Therapy, 2009, 26 : 249 - 262
  • [8] Management of a Prediabetes Case With the DPP-4 Inhibitor Sitagliptin
    Johnson, Jeremy L.
    O'Neal, Katherine S.
    Pack, Christopher C.
    Kim, Minhye K.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (06) : 811 - 815
  • [9] Linagliptin: A New DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus
    Toth, Peter P.
    POSTGRADUATE MEDICINE, 2011, 123 (04) : 46 - 53
  • [10] DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetes
    Deacon, Carolyn F.
    Carr, Richard D.
    Holst, Jens J.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 1780 - 1794
12345